(Q57101677)

1

0 references

Eiju Uchinuma

2

0 references

Yasuhiro Matsumoto

3

0 references

Yoshimitsu Kuroyanagi

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs

4

0 references

language of work or name

English

0 references

publication date

2008

0 references

published in

0 references

volume

11

0 references

issue

4

0 references

page(s)

221-4

0 references

cites work

An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10047-008-0428-1

Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts

21 January 2018

1 reference

12 December 2020

A study of cytokines released from fibroblasts in cultured dermal substitute.

1 reference

12 December 2020

Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS).

1 reference

12 December 2020

Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation

1 reference

12 December 2020

Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test

1 reference

12 December 2020

Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test

1 reference

12 December 2020

Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.

1 reference

12 December 2020

Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute.

1 reference

12 December 2020

Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.

1 reference

12 December 2020

Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation

1 reference

12 December 2020

Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing

1 reference

12 December 2020

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg.

1 reference

12 December 2020

Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa.

1 reference

12 December 2020

Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix

1 reference

12 December 2020

Establishment of banking system for allogeneic cultured dermal substitute.

1 reference

12 December 2020

Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts

1 reference

12 December 2020

Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro.

1 reference

12 December 2020

Intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute.

1 reference

12 December 2020

The possibility of long-term cryopreservation of cultured dermal substitute.

1 reference

12 December 2020